Thyroid eye disease (TED) therapy Tepezza – the best asset in Amgen's $26 billion takeover of Horizon in 2023 – could possibly be experiencing Opposition from A simpler-to-dose different from Sling Therapeutics. Hepatic transaminases were being all promptly settled instead of link